Contact
Please use this form to send email to PR contact of this press release:
Avotres Announces Achieving Primary Endpoint of its Phase 1/2 Clinical Trial of AVT001 in Patients with Type 1 Diabetes
TO:
Emmie Fan
Avotres Inc.
+1 973-487-6972